NCT02913014 is a NA clinical trial of No AAD post Ablation. in Atrial Fibrillation, sponsored by Prisma Health-Midlands.

Who is sponsoring NCT02913014?

NCT02913014 is sponsored by Prisma Health-Midlands.

What drugs are being tested in NCT02913014?

Interventions in NCT02913014: No AAD post Ablation..

What condition does NCT02913014 study?

NCT02913014 studies Atrial Fibrillation.

Is NCT02913014 still recruiting?

NCT02913014 is currently completed. Last updated 31 October 2024.

Last reviewed 2024-10-31 · How we verify

NCT02913014

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Comparison of Recurrence of Atrial Fibrillation Post Cryoballon Ablation During the 90-day Blanking Period-with and Without Anti-arrhythmic Drug Therapy

Completed NA Last updated 31 October 2024

What this trial tests

NA trial testing No AAD post Ablation. in Atrial Fibrillation in 50 participants. Completed in 31 December 2020.

Timeline

28 June 2017

Primary endpoint
31 December 2020

31 December 2020

Quick facts

Lead sponsor	Prisma Health-Midlands
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	other
Enrollment	50
Start date	28 June 2017
Primary completion	31 December 2020
Estimated completion	31 December 2020
Sites	1 location across United States

Drugs / interventions tested

No AAD post Ablation.

Conditions studied

Atrial Fibrillation — all drugs for Atrial Fibrillation →

Sponsor

Prisma Health-Midlands — full company profile →

Who can join

Adults 18 to 80, any sex, with Atrial Fibrillation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study is being done to find out if patients taking Anti Arrhythmia Drugs (AADs) after cryoballoon ablation for atrial fibrillation, compared to patients who do not take Anti- Arrhythmic Drugs after an ablation affect Atrial Fibrillation from coming back. The study will also look at the side effects of the AADs.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Oral Class I and III antiarrhythmic drugs for maintaining sinus rhythm after catheter ablation of atrial fibrillation.
Bray JJH, Warraich M, Whitfield MG, Peter CU, et al · · 2023 · cited 2× · PMID 36915032 · DOI 10.1002/14651858.cd013765.pub2

Verify or expand the search:

Other recruiting trials for Atrial Fibrillation

Currently open trials in the same condition.

NCT07429214 — A Study of VARIPULSE Catheter and TRUPULSE Generator With VARIPULSE Pro Software in Participants With PAF or PsAF · NA · recruiting
NCT07271238 — Feasibility Study on the VERAFEYE Imaging and Navigation System for Guided Catheter Ablation Procedures · NA · recruiting
NCT07388108 — Atrial Dyssynchrony to Predict Arrhythmias in the Postoperative Setting of Cardiovascular Surgery. · recruiting
NCT07428967 — AV Node Ablation and CONDUCTion System Pacing for Atrial Fibrillation With Preserved Left Ventricular Function · NA · recruiting
NCT06650995 — AlEX-DHF: Ablation and Exercise in Diastolic Heart Failure · NA · recruiting

Other Prisma Health-Midlands trials

Trials by the same sponsor.

NCT05678231 — Zero Degree Knee Positioner for Improved Earley Knee Extension Following Total Knee Arthroplasty · NA · active not recruiting
NCT05281562 — Immunonutrition for Diabetic Foot Ulcers · Phase 2, PHASE3 · terminated
NCT05707013 — HP Arize 3D Orthotics for Planar Fasciitis · NA · active not recruiting
NCT05138549 — Astaxanthin for Management of Inflammation in Knee Osteoarthritis · Phase 2, PHASE3 · terminated
NCT04771741 — Opiate Free Multimodal Pain Pathway in Elective Foot and Ankle Surgery: A Prospective Study · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02913014 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Prisma Health-Midlands
Last refreshed: 31 October 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02913014.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing